rs913934445
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PM1PM2PP2PP3_ModeratePP5
The NM_000166.6(GJB1):c.148T>C(p.Ser50Pro) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S50A) has been classified as Uncertain significance.
Frequency
Consequence
NM_000166.6 missense
Scores
Clinical Significance
Conservation
Publications
- Charcot-Marie-Tooth disease X-linked dominant 1Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia, ClinGen, Labcorp Genetics (formerly Invitae)
- X-linked progressive cerebellar ataxiaInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000166.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GJB1 | NM_000166.6 | MANE Select | c.148T>C | p.Ser50Pro | missense | Exon 2 of 2 | NP_000157.1 | ||
| GJB1 | NM_001097642.3 | c.148T>C | p.Ser50Pro | missense | Exon 2 of 2 | NP_001091111.1 | |||
| GJB1 | NM_001440770.1 | c.148T>C | p.Ser50Pro | missense | Exon 3 of 3 | NP_001427699.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GJB1 | ENST00000361726.7 | TSL:1 MANE Select | c.148T>C | p.Ser50Pro | missense | Exon 2 of 2 | ENSP00000354900.6 | ||
| GJB1 | ENST00000374029.2 | TSL:5 | c.148T>C | p.Ser50Pro | missense | Exon 2 of 2 | ENSP00000363141.1 | ||
| GJB1 | ENST00000447581.2 | TSL:5 | c.148T>C | p.Ser50Pro | missense | Exon 3 of 3 | ENSP00000407223.2 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not provided Pathogenic:1
A variant that is likely pathogenic has been identified in the GJB1 gene. The S50P variant has been previously reported in two families with a clinical diagnosis of axonal CMT (Latour et al., 1997). The S50P variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The S50P variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Missense variants in nearby residues (S49P/Y, F51L, C53S/Y) have been reported in the Human Gene Mutation Database in association with CMT (Stenson et al., 2014), supporting the functional importance of this region of the protein. Therefore, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded
not specified Uncertain:1
Charcot-Marie-Tooth disease Uncertain:1
Charcot-Marie-Tooth Neuropathy X Uncertain:1
This sequence change replaces serine with proline at codon 50 of the GJB1 protein (p.Ser50Pro). The serine residue is moderately conserved and there is a moderate physicochemical difference between serine and proline. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with Charcot-Marie-Tooth disease (PMID: 10732813). ClinVar contains an entry for this variant (Variation ID: 430122). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at